Biovica International AB (publ) (FRA:9II)

Germany · Delayed Price · Currency is EUR

0.0132

+0.0034 (34.69%)

At close: Jan 30, 2026

Revenue by Product

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015	Apr '14 Apr 30, 2014	Apr '13 Apr 30, 2013
DiviTum Kits Research Use Only	3.12M
DiviTum Kits Research Use Only Growth	-30.63%
Tests (In Vitro Diagnostics) - United States	2.95M
Tests (In Vitro Diagnostics) - United States Growth	274.75%
Research Test	2.28M
Research Test Growth	14.00%
DiviTum Kits (In Vitro Diagnostics) - European Union	264.00K

Revenue by Geography

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Apr '15 Apr 30, 2015	Apr '14 Apr 30, 2014	Apr '13 Apr 30, 2013
United States	7.55M
United States Growth	35.27%
Rest of World	536.00K
Rest of World Growth	80.47%
European Union	531.00K
European Union Growth	-61.21%